Follow-The-Filings

Security · featured owners

DXCM Dexcom Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 1.1%
  • $29M
  • 2 add 1 exit

DXCM (Dexcom Inc.) is held in 3 featured 13F books as of 2026 Q2. Nathan Fischel - Dafna Capital Management is the largest tracked holder by portfolio weight (1.1%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 1.1% (Nathan Fischel - Dafna Capital Management) · not free-float ownership

  1. Nathan Fischel 1.1%
  2. David Witzke add 1.1%
  3. Ron Baron add 0.02%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Ron Baron - Bamco Inc. (Baron Capital) 2026 Q2 0.02% Add +1.7% 245,000 $17M history
David Witzke - Avidity Partners Management 2026 Q2 1.1% Add +11.1% 100,000 $7M history
Nathan Fischel - Dafna Capital Management 2026 Q2 1.1% Hold 86,279 $6M history
First Eagle Investment Management exited 2026 Q2 last 2026 Q1 <0.01% Exit 0.00% 58 $4K history

3 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 5 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 14 rows shown

Filed Form Detail Links
4 Period Sep 10, 2026 Filing Doc
4 Period Sep 10, 2026 Filing Doc
4 Period Aug 27, 2026 Filing Doc
4 Period Aug 22, 2026 · 4 forms Filing Doc
4 Period Aug 20, 2026 Filing Doc
4 Period Aug 14, 2026 Filing Doc
4 Period Aug 12, 2026 · 2 forms Filing Doc
4 Period Jul 31, 2026 Filing Doc
4 Period Jul 20, 2026 Filing Doc
4 Period Jul 15, 2026 Filing Doc
4 Period Jul 6, 2026 Filing Doc
4 Period Jun 15, 2026 · 2 forms Filing Doc
4 Period Jun 3, 2026 Filing Doc
4 Period May 28, 2026 · 7 forms Filing Doc

Updated about 13 hours ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $3.62B $4.03B $4.66B
Gross profit $2.29B $2.44B $2.8B
Gross margin * 63.2% 60.5% 60.1%
Net income $541.5M $576.2M $836.3M
Net margin * 14.9% 14.3% 17.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $4.43B $4.3B $4.03B
Total non-current assets * $1.84B $2.18B $2.31B
Total assets $6.26B $6.48B $6.34B
Total current liabilities $1.56B $2.93B $2.14B
Total non-current liabilities * $2.64B $1.45B $1.45B
Total equity $2.07B $2.1B $2.75B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $0.748B $0.99B $1.44B
Cash from investing -$507.2M -$207.5M $536M
Cash from financing -$0.319B -$0.735B -$1.69B
Net change in cash -$75.8M $39.8M $311.8M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders